Form 4: Health Catalyst Executive Linda Llewelyn Sells Shares Under 10b5-1 Plan

Linda Llewelyn, Chief People Officer of Health Catalyst, Inc., sold 6,441 shares of common stock at a price of $5.4266 per share on February 18, 2025, under a pre-arranged trading plan.

Summary

• On February 18, 2025, Linda Llewelyn, the Chief People Officer of Health Catalyst, Inc., sold 6,441 shares of the company's common stock.
• The sale was executed at a price of $5.4266 per share.
• This transaction was conducted under a pre-arranged trading plan adopted on March 12, 2024, in accordance with Rule 10b5-1.
• Following the transaction, Llewelyn directly owns 85,819 shares of Health Catalyst common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a stock sale under a pre-existing 10b5-1 plan, which is a common and legal practice.

Industry Context

Executive stock sales are a common occurrence and are often related to personal financial planning. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on inside information at the time of the transaction.

Stakeholder Impact

• The stock sale by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates

Keywords

Health Catalyst, HCAT, Linda Llewelyn, Chief People Officer, Form 4, Stock Sale, Rule 10b5-1, Insider Trading